Sleep characterization with smart wearable devices: a call for standardization and consensus recommendations.


Journal

Sleep
ISSN: 1550-9109
Titre abrégé: Sleep
Pays: United States
ID NLM: 7809084

Informations de publication

Date de publication:
12 Dec 2022
Historique:
received: 28 03 2022
revised: 06 07 2022
pubmed: 2 8 2022
medline: 15 12 2022
entrez: 1 8 2022
Statut: ppublish

Résumé

The general public increasingly adopts smart wearable devices to quantify sleep characteristics and dedicated devices for sleep assessment. The rapid evolution of technology has outpaced the ability to implement validation approaches and demonstrate relevant clinical applicability. There are untapped opportunities to validate and refine consumer devices in partnership with scientists in academic institutions, patients, and the private sector to allow effective integration into clinical management pathways and facilitate trust in adoption once reliability and validity have been demonstrated. We call for the formation of a working group involving stakeholders from academia, clinical care and industry to develop clear professional recommendations to facilitate appropriate and optimized clinical utilization of such technologies.

Identifiants

pubmed: 35913733
pii: 6652912
doi: 10.1093/sleep/zsac183
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of Sleep Research Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Mathias Baumert (M)

School of Electrical and Electronic Engineering, The University of Adelaide, Adelaide, Australia.

Martin R Cowie (MR)

School of Cardiovascular Medicine, Faculty of Medicine & Lifesciences, King's College London, London, UK.
Royal Brompton Hospital (Guy's & St Thomas' NHS Foundation Trust), London, UK.

Susan Redline (S)

Department of Medicine, Division of Sleep, Circadian Rhythm, and Neurobiology, Brigham and Women's Hospital, Boston, MA, USA.
Department of Medicine, Division of Sleep, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Reena Mehra (R)

Sleep Disorders Research Program, Sleep Disorders Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.

Michael Arzt (M)

Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.

Jean-Louis Pépin (JL)

HP2 Laboratory, INSERM U1300, Univ. Grenoble Alpes, and EFCR Laboratory, Grenoble Alpes University Hospital, Grenoble, France.

Dominik Linz (D)

Department of Cardiology, Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands.
Department of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH